Karin Nordin

7PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Exercise physiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 02, 2024
Effects of heavy-load strength training during (neo-)adjuvant chemotherapy on muscle strength, muscle fiber size, myonuclei, and satellite cells in women with breast cancer.

Olav Vikmoen, Emelie Strandberg, Karianne Vassbakk Svindland

|Apr 19, 2023
Cost-effectiveness of different exercise intensities during oncological treatment in the Phys-Can RCT.

Anna-Karin Ax, Magnus Husberg, Birgitta Johansson

|Nov 11, 2022
Effects of High and Low-To-Moderate Intensity Exercise During (Neo-) Adjuvant Chemotherapy on Muscle Cells, Cardiorespiratory Fitness, and Muscle Function in Women With Breast Cancer: Protocol for a Randomized Controlled Trial.

Olav Vikmoen, Tor Helge Wiestad, Inger Thormodsen

|Oct 21, 2022
Pre-treatment levels of inflammatory markers and chemotherapy completion rates in patients with early-stage breast cancer.

Tim Schauer, Anna Henriksson, Emelie Strandberg

|May 24, 2022
Long-term resource utilisation and associated costs of exercise during (neo)adjuvant oncological treatment: the Phys-Can project.

Anna-Karin Ax, Magnus Husberg, Birgitta Johansson

|Apr 08, 2022
Short- and long-term effect of high versus low-to-moderate intensity exercise to optimise health-related quality of life after oncological treatment-results from the Phys-Can project.

Anna-Karin Ax, Birgitta Johansson, Johan Lyth

Pageof 2

Frequent Collaborators

5 joint publications

Ingrid Demmelmaier

4 joint publications

Birgitta Johansson

4 joint publications

Sveinung Berntsen

3 joint publications

Anna-Karin Ax